1Rybak LD,Rosenthal DI.Radiological imaging for the diagnosis of bone metastases.Q J Nucl Med,2001,45:53-64.
2Hamaoka T,Madewell JE,Podoloff DA,et al.Bone imaging in metastatic breast cancer.J Clin Oncol,2004,22:2942-2953.
3Blake GM,Park-Holohan SJ,Cook GJ,et al.Quantitative studies of bone with the use of 18 F-fluoride and ^99Tc^m-methylene diphosphonate.Semin Nucl Med,2001,31:28-49.
4Vanel D,Dromain C,Tardivon A.MRI of bone marrow disorders.Eur Radiol,2000,10:224-229.
5Daldrup-Link HE,Franzius C,Link TM,et al.Whole body MR imaging for detection of bone metastases in children and young adults.AJR,2001,177:229-236.
2Hsia TC, Shen YY, Yen RF, et al. Comparing whole body ^18F-2-deoxyglucose positron emission tomography and ^99Tc^m-methylene diphosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma, 2002, 49: 267-271.
3Ohta M, Tokuda Y, Suzuki Y, et al. Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with ^99Tc^m-MDP bone scintigraphy. Nucl Med Commun, 2001, 22: 875-879.
4Yang SN, Liang JA, Lin FJ, et al. Comparing whole body ^18F-2-deoxyglucose positron emission tomography and ^99Tc^m-methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer. J Cancer Res Clin Oncol, 2002, 128: 325-328.
5Chung JK, Kim YK, Yoon JK, et al. Diagnostic usefulness of ^18F-FDG whole body PET in detection of bony metastases compared to ^99Tc^m-MDP bone scan. J Nucl Med, 1999, 40: 96P.
6Shreve PD, Grossman HB, Gross MD, et al. Metastatic prostate cancer:initial findings of PET with 2-deoxy-2-^18F-fluoro-D-glucose. Radiology,1996, 199: 751-756.
7Cook GJ, Houston S, Rubens R, et al. Detection of bone metastases in breast cancer by ^18F-FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol, 1998, 16: 3375-3379.
8Daldrup-Link HE, Franzius C, Link TM, et al. Whole-body MR imaging for detection of bone metastases in children mad young adults: comparison with skeletal scintigraphy and FDG PET. Am J Roentgenol, 2001, 177:229-236.
9Gulenchyn KY, Papoff W. ^99Tc^m-MDP scintigraphy: an insensitive tool for the detection of bone marrow metastases. Clin Nucl Med, 1987, 12: 45-46.
10Wagnar HN. Highlights 2001 lecture: against all odds, nuclear medicine has thrived. J Nucl Med,2001,42:12N-30N.
